Omnichannel diagnostics platform Redcliffe Lifetech raised $61 Mn in Series B funding
- ByStartupStory | May 6, 2022
Redcliffe, founded in 2018 by Dheeraj Jain and Ashish Dubey, is an omnichannel diagnostics platform that delivers diagnostic services to 22 labs which are in its network, across 14 cities. The omnichannel infrastructure of Redcliffe Lifetech combines the online channels with a fleet of 400 phlebotomists who operate in over 100 cities with home sample collection and an offline network of 500 collection centers.
The platform has raised $61 Million in its Series B round which was led by LeapFrog Investments and participation was also done from Schroders, LC Nueva, Growth Spark Ventures, Healthquad, and Chiratae Ventures and Alkemi Venture Partners who have already have had investments in the company. In the company’s Series A round last year, it had raised $10 Million.
The investment received from the Series B funding will be used to expand Redcliffe’s geographic reach in India and also to scale Redcliffe’s platform, and increase its offering in products to radiology, disease data profiling, and lifestyle management. This funding would help the platform improve India’s healthcare from treatment to early diagnosis and prevention.
The company has 3,500 different pathology and specialized tests which also includes genetics. The prices of these pathology centers have been reported to be around 25-60% less than the traditional competitors. The funding would help them reach over 500 million Indians in the next five years.
Follow Startup Story
Related Posts
